Risk factors and mortality of SARS-CoV-2 reinfection during the Omicron era in Taiwan: A nationwide population-based cohort study
CONCLUSION: During the SARS-CoV-2 Omicron era, reinfection patients were observed to have an increased risk of all-cause mortality. To reduce the disease burden and minimize the risk of reinfection, it is crucial for vulnerable patients to receive full vaccination and adhere to recommended precautions.PMID:37978019 | DOI:10.1016/j.jmii.2023.10.013
Source: Journal of Microbiology, Immunology, and Infection - Category: Microbiology Authors: Yi-Hsuan Chen Cheng-Yi Lee Hao-Yuan Cheng Chiu-Mei Chen Yu-Neng Cheuh Chia-Lin Lee Hung-Wei Kuo Source Type: research
More News: Allergy & Immunology | Chia | Covid Vaccine | COVID-19 | Epidemics | Epidemiology | Microbiology | Outbreaks | SARS | Study | Taiwan Health | Vaccines